Launxp Biomedical Co., Ltd. · TPEX:6876

Launxp Biomedical Co., Ltd. financial statements

Launxp Biomedical Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2024FY2023FY2022FY2021
Revenue2.48M11.0K00
Cost of revenue199.0K000
Gross profit2.29M11.0K00
Research and development37.6M43.7M19.7M15.1M
Selling, general and administrative46.9M37.4M23.9M8.18M
Operating income-82.3M-81.0M-43.6M-34.8M
Depreciation and amortization2.40M2.41M2.35M1.60M
EBITDA-79.9M-78.6M-41.3M-33.2M
Interest expense42.0K167.0K195.0K60.0K
Income before tax-82.1M-80.9M-43.6M-34.7M
Net income-82.6M-80.9M-43.6M-34.7M
Earnings per share, basic-2.55-2.51-1.35-1.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents98.4M179.7M15.2M34.1M
Short-term investments27.0M
Receivables09.00K0
Current assets104.9M185.5M24.2M64.2M
Total assets123.9M206.5M32.4M73.9M
Accounts payable2.38M1.94M411.0K0
Current liabilities13.9M21.5M7.58M5.17M
Total liabilities15.0M23.2M10.2M8.65M
Shareholders' equity108.9M183.3M22.2M65.2M
Shares outstanding48.0M32.4M32.2M32.2M32.2M

Cash flow

LineFY2024FY2023FY2022FY2021
Cash from operations-76.7M-59.1M-44.2M-29.0M
Capital spending-316.0K-3.31M-804.0K-4.24M
Free cash flow-77.0M-62.5M-45.0M-33.2M
Change in cash-81.4M164.5M-18.9M2.20M